{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:42:25Z","timestamp":1774878145578,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,18]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Common variable immunodeficiency (CVID) is the most common severe adult primary immunodeficiency and is characterized by a failure to produce antibodies leading to recurrent predominantly sinopulmonary infections. Improvements in the prevention and treatment of infection with immunoglobulin replacement and antibiotics have resulted in malignancy, autoimmune, inflammatory and lymphoproliferative disorders emerging as major clinical challenges in the management of patients who have CVID. In a proportion of CVID patients, inflammation manifests as granulomas that frequently involve the lungs, lymph nodes, spleen and liver and may affect almost any organ. Granulomatous lymphocytic interstitial lung disease (GLILD) is associated with a worse outcome. Its underlying pathogenic mechanisms are poorly understood and there is limited evidence to inform how best to monitor, treat or select patients to treat. We describe the use of combined 2-[(18)F]-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG PET-CT) scanning for the assessment and monitoring of response to treatment in a patient with GLILD. This enabled a synergistic combination of functional and anatomical imaging in GLILD and demonstrated a widespread and high level of metabolic activity in the lungs and lymph nodes. Following treatment with rituximab and mycophenolate there was almost complete resolution of the previously identified high metabolic activity alongside significant normalization in lymph node size and lung architecture. The results support the view that GLILD represents one facet of a multi-systemic metabolically highly active lymphoproliferative disorder and suggests potential utility of this imaging modality in this subset of patients with CVID.<\/jats:p>","DOI":"10.1111\/cei.12856","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T01:56:40Z","timestamp":1480384600000},"page":"138-145","source":"Crossref","is-referenced-by-count":47,"title":["FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)"],"prefix":"10.1093","volume":"187","author":[{"given":"S","family":"Jolles","sequence":"first","affiliation":[{"name":"Department of Immunology, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Carne","sequence":"additional","affiliation":[{"name":"Department of Immunology, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Brouns","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Neville Hall Hospital, Abergavenny, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"El-Shanawany","sequence":"additional","affiliation":[{"name":"Department of Immunology, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Immunology, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Marshall","sequence":"additional","affiliation":[{"name":"Department of Radiology, PETIC, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Fielding","sequence":"additional","affiliation":[{"name":"Department of Radiology, PETIC, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"2021120808030666900_cei12856-bib-0001","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaip.2013.09.015","article-title":"The variable in common variable immunodeficiency: a disease of complex phenotypes","volume":"1","author":"Jolles","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2021120808030666900_cei12856-bib-0002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"2021120808030666900_cei12856-bib-0003","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"2021120808030666900_cei12856-bib-0004","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MCP.0b013e3283642c47","article-title":"Common variable immunodeficiency-associated granulomatous and interstitial lung disease","volume":"19","author":"Prasse","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"2021120808030666900_cei12856-bib-0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/cei.12178","article-title":"New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin","volume":"174","author":"Ameratunga","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"2021120808030666900_cei12856-bib-0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2021120808030666900_cei12856-bib-0007","author":"Thon","year":"2014"},{"key":"2021120808030666900_cei12856-bib-0008","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejrad.2004.09.005","article-title":"The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency","volume":"54","author":"Park","year":"2005","journal-title":"Eur J Radiol"},{"key":"2021120808030666900_cei12856-bib-0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09031936.00189011","article-title":"Granulomatosis-associated common variable immunodeficiency disorder: a case\u2013control study versus sarcoidosis","volume":"41","author":"Bouvry","year":"2013","journal-title":"Eur Respir J"},{"key":"2021120808030666900_cei12856-bib-0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2021120808030666900_cei12856-bib-0011","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-215624","article-title":"Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency","volume":"2016","author":"Pathria","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2021120808030666900_cei12856-bib-0012","doi-asserted-by":"publisher","DOI":"10.1111\/crj.12511","article-title":"Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency","author":"Tashtoush","year":"2016","journal-title":"Clin Respir J"},{"key":"2021120808030666900_cei12856-bib-0013","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2213-2600(15)00202-7","article-title":"Lung disease in primary antibody deficiency","volume":"3","author":"Verma","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2021120808030666900_cei12856-bib-0014","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)","volume":"33","author":"Chase","year":"2013","journal-title":"J Clin Immunol"},{"key":"2021120808030666900_cei12856-bib-0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.crad.2015.03.010","article-title":"FDG PET\/CT in infection and inflammation\u2013current and emerging clinical applications","volume":"70","author":"Vaidyanathan","year":"2015","journal-title":"Clin Radiol"},{"key":"2021120808030666900_cei12856-bib-0016","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"2021120808030666900_cei12856-bib-0017","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.crad.2016.02.023","article-title":"PET-CT in the UK: current status and future directions","volume":"71","author":"Scarsbrook","year":"2016","journal-title":"Clin Radiol"},{"key":"2021120808030666900_cei12856-bib-0018","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1513\/AnnalsATS.201511-728OC","article-title":"Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease","volume":"13","author":"Mannina","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2021120808030666900_cei12856-bib-0019","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/00365540600978955","article-title":"Common variable immune deficiency and lung transplantation","volume":"39","author":"Burton","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"2021120808030666900_cei12856-bib-0020","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/qjmed\/95.10.655","article-title":"Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings","volume":"95","author":"Thickett","year":"2002","journal-title":"Q J Med"},{"key":"2021120808030666900_cei12856-bib-0021","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaip.2015.07.004","article-title":"Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings","volume":"3","author":"Maglione","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2021120808030666900_cei12856-bib-0022","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10875-009-9351-3","article-title":"Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes","volume":"30","author":"Arumugakani","year":"2010","journal-title":"J Clin Immunol"},{"key":"2021120808030666900_cei12856-bib-0023","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2249.2012.04643.x","article-title":"T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections","volume":"170","author":"Bateman","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"2021120808030666900_cei12856-bib-0024","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/jclinpath-2012-201046","article-title":"CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells","volume":"66","author":"Carter","year":"2013","journal-title":"J Clin Pathol"},{"key":"2021120808030666900_cei12856-bib-0025","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jaci.2012.05.046","article-title":"Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts","volume":"130","author":"Chapel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2021120808030666900_cei12856-bib-0026","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","article-title":"Unravelling the complexity of T cell abnormalities in common variable immunodeficiency","volume":"178","author":"Giovannetti","year":"2007","journal-title":"J Immunol"},{"key":"2021120808030666900_cei12856-bib-0027","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.anai.2010.04.015","article-title":"Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors","volume":"104","author":"Gregersen","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021120808030666900_cei12856-bib-0028","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2249.2009.03913.x","article-title":"Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency","volume":"156","author":"Horn","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021120808030666900_cei12856-bib-0029","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","article-title":"Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021120808030666900_cei12856-bib-0030","doi-asserted-by":"crossref","first-page":"e6269","DOI":"10.1371\/journal.pone.0006269","article-title":"A decreased frequency of regulatory T cells in patients with common variable immunodeficiency","volume":"4","author":"Melo","year":"2009","journal-title":"PLOS ONE"},{"key":"2021120808030666900_cei12856-bib-0031","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti","year":"2011","journal-title":"J Clin Immunol"},{"key":"2021120808030666900_cei12856-bib-0032","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"2021120808030666900_cei12856-bib-0033","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10875-015-0172-2","article-title":"Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies","volume":"35","author":"Milito","year":"2015","journal-title":"J Clin Immunol"},{"key":"2021120808030666900_cei12856-bib-0034","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1378\/chest.10-3147","article-title":"Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity","volume":"140","author":"Serra","year":"2011","journal-title":"Chest"},{"key":"2021120808030666900_cei12856-bib-0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jclinpath-2015-203351","article-title":"T-cell abnormalities in common variable immunodeficiency: the hidden defect","volume":"69","author":"Wong","year":"2016","journal-title":"J Clin Pathol"},{"key":"2021120808030666900_cei12856-bib-0036"},{"key":"2021120808030666900_cei12856-bib-0037","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/ACI.0000000000000218","article-title":"The autoimmune conundrum in common variable immunodeficiency disorders","volume":"15","author":"van de Ven","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12856","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/187\/1\/138\/41642555\/cei12856.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/187\/1\/138\/41642555\/cei12856.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T07:51:14Z","timestamp":1657871474000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/187\/1\/138\/6412048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,28]]},"published-print":{"date-parts":[[2016,12,18]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12856","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2017,1]]},"published":{"date-parts":[[2016,11,28]]}}}